AbulMagd et al., 2020 - Google Patents
Immunomodulatin Effect of Inactivated Parapox Virus (Zylexis) on Sheep Crop Vaccinated with Inactivated RVF VaccineAbulMagd et al., 2020
View PDF- Document ID
- 969260411960115324
- Author
- AbulMagd D
- et al.
- Publication year
- Publication venue
- EC Veterinary Science
External Links
Snippet
Cronicon Page 1 Cronicon OPENACCESS EC VETERINARY SCIENCE Research Article
Immunomodulatin Effect of Inactivated Parapox Virus (Zylexis) on Sheep Crop Vaccinated with
Inactivated RVF Vaccine Citation: AbulMagd DM., et al. “Immunomodulatin Effect of Inactivated …
- 229960005486 vaccines 0 title abstract description 68
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1291012C (en) | Altered strain of modified vaccinia virus ankara (MVA) | |
| DE60314823T3 (en) | MODIFIED VARIANT OF VACCINIA ANKARA VIRUS AS VACCINE FOR NEWBORN | |
| CA3081072A1 (en) | Adjuvant and vaccine compositions | |
| KR20040044942A (en) | Interleukin-12 as a veterinary vaccine adjuvant | |
| CN111808826B (en) | Porcine Senecavirus A SVA/CH-Fuj Strain and Its Application | |
| CN104258389A (en) | Vaccine composition as well as preparation method and application thereof | |
| CN108452298A (en) | A kind of technique producing yellow fever attenuated live vaccine with SPF chick-embryo cells | |
| AbulMagd | Immunomodulatin Effect of Inactivated Parapox Virus (Zylexis) on Sheep Crop Vaccinated with Inactivated RVF Vaccine | |
| GB1596653A (en) | Vaccine | |
| TWI589586B (en) | Uses of starch binding protein (sbp)-tagged immunostimulatory protein | |
| JP2007068401A (en) | West nile virus vaccine | |
| Grubman | New approaches to rapidly control foot-and-mouth disease outbreaks | |
| CN111467488B (en) | Water-soluble composite immunoadjuvant and application thereof | |
| Townsend et al. | Efficacy of a cold-adapted, modified-live virus influenza vaccine: a double-blind challenge trial | |
| Evstifeev et al. | Development of associated vaccine against Piv-3, Ibr, Bvd and chlamidiosis of cattle | |
| KR102615970B1 (en) | Hyperimmune Serum Against Diarrhea Causing Viruses in Bovine, Composition Containing Thereof, Method of Producing Thereof, and Method of Preventing and Treating Bovine Viral Diarrhea Using Thereof | |
| CN111150724B (en) | Application of valine in the preparation of medicine for treating or preventing avian influenza virus infection | |
| CN117887648B (en) | Recombinant lactic acid bacteria composition expressing H9N2 subtype avian influenza virus antigen protein and application thereof | |
| US3122477A (en) | Hog cholera vaccine and method of making the same | |
| El-Sayed et al. | Effect of Carbopol as an Immune-Stimulant in Bovine Vaccination against Foot and Mouth Disease | |
| Cummins et al. | Low dosage of interferon to enhance vaccine efficiency in feedlot calves | |
| RU2240820C2 (en) | Preparation for preventing infectious keratoconjunctivitis in cattle and method for preventing this disease | |
| RU2032423C1 (en) | Vaccine against mink viral enteritis, botulism and pseudomonosis | |
| RU2181283C2 (en) | Method for preventing reproductive- respiratory syndrome in swine | |
| Kareem et al. | Improvement of Newcastle disease virus vaccine by using gold nanoparticles and some natural food additives |